Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson's disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.

Therapeutics

Inhibikase Therapeutics, Inc.

Inhibikase Therapeutics, Inc.'s headquarters in ATLANTA, GA, United States

Milton Werner

Tim Pigot

Description

People

Jobs